17.30Open17.30Pre Close0 Volume6 Open Interest95.00Strike Price0.00Turnover111.81%IV-1.69%PremiumDec 20, 2024Expiry Date18.59Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9734Delta0.0080Gamma4.10Leverage Ratio-0.0484Theta-0.0054Rho-3.99Eff Leverage0.0046Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet